Tokyo Tape
Sign in
← Toho Holdings

Quarterly report · Q3

8129.TEDINET S100SULP
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
MetricValuePeriodScopeSource row
Revenue¥1.12T2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥1.39T2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥1.06T2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥11.6bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥11.2bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥13.6bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥19.2bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥13.4bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥20.3bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥14.4bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥13.5bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥13.6bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥9.5bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥13.5bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥9.6bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥804.9bnat 2023-12-31Cons.Assets
Total assets¥715.3bnat 2023-03-31Cons.Assets
Total assets¥794.4bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥561.2bnat 2023-12-31Cons.Liabilities
Total liabilities¥472.4bnat 2023-03-31Cons.Liabilities
Net assets / equity¥243.7bnat 2023-12-31Cons.Net assets
Net assets / equity¥242.9bnat 2023-03-31Cons.Net assets
Net assets / equity¥240.4bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥128.9bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥86.2bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥207.252023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥73.142023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥196.72022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥136.092022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥85.92022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥186.22023-04-01 → 2023-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥180.672022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥125.12022-04-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio30.3%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio33.9%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio30.2%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥44.5bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥44.5bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥2.6bn
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentrevenue2023-04-01 → 2023-12-31¥70.4bn
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentrevenue external2023-04-01 → 2023-12-31¥70.4bn
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥9m
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentsegment profit2023-04-01 → 2023-12-31¥1.4bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue2023-04-01 → 2023-12-31¥8.0bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue external2023-04-01 → 2023-12-31¥1.8bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥6.2bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentsegment profit2023-04-01 → 2023-12-31¥686m
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentrevenue2023-04-01 → 2023-12-31¥1.08T
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentrevenue external2023-04-01 → 2023-12-31¥1.04T
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥37.3bn
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentsegment profit2023-04-01 → 2023-12-31¥11.8bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥4.4bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥3.4bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥1.0bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentsegment profit2023-04-01 → 2023-12-31¥258m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥1.16T
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥1.12T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-12-31¥44.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥14.2bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥43.4bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥43.4bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥1.1bn
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentrevenue2022-04-01 → 2022-12-31¥68.8bn
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentrevenue external2022-04-01 → 2022-12-31¥68.8bn
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥4m
jpcrp040300-q3r_E02608-000Dispensing Pharmacyreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.7bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue2022-04-01 → 2022-12-31¥7.4bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.6bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥5.8bn
jpcrp040300-q3r_E02608-000Medical Products Manufacturing And Salesreportable segmentsegment profit2022-04-01 → 2022-12-31¥715m
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentrevenue2022-04-01 → 2022-12-31¥1.02T
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentrevenue external2022-04-01 → 2022-12-31¥986.2bn
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥36.4bn
jpcrp040300-q3r_E02608-000Medical Products Retailreportable segmentsegment profit2022-04-01 → 2022-12-31¥9.4bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥4.9bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥3.8bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥1.2bn
jpcrp040300-q3r_E02608-000Other Related Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥449m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥1.10T
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥1.06T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥43.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥12.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 419
ItemContextValueUnit
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member13638000
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member－
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member13638000
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.1742
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row2Member33000
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row2Member－
Total number of shares held treasury shares etcCurrentQuarterInstant_Row2Member33000
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row2Member0.0004
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row3Member1000
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row3Member－
Total number of shares held treasury shares etcCurrentQuarterInstant_Row3Member1000
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row3Member0.0000
Number of shares held in own name treasury shares etcCurrentQuarterInstant13672000
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant13672000
Shareholding ratio treasury shares etcCurrentQuarterInstant0.1746
Cash and depositsPrior1YearInstant86201000000JPY
Cash and depositsCurrentQuarterInstant128878000000JPY
Notes and accounts receivable tradePrior1YearInstant316696000000JPY
Notes and accounts receivable tradeCurrentQuarterInstant358902000000JPY
Merchandise and finished goodsPrior1YearInstant91217000000JPY
Merchandise and finished goodsCurrentQuarterInstant94450000000JPY
Raw materials and suppliesPrior1YearInstant206000000JPY
Raw materials and suppliesCurrentQuarterInstant141000000JPY
Other caPrior1YearInstant39573000000JPY
Other caCurrentQuarterInstant45904000000JPY
Allowance for doubtful accounts caPrior1YearInstant-376000000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-390000000JPY
Current assetsPrior1YearInstant533519000000JPY
Current assetsCurrentQuarterInstant627887000000JPY
Property plant and equipmentPrior1YearInstant90270000000JPY
Property plant and equipmentCurrentQuarterInstant88610000000JPY
GoodwillPrior1YearInstant514000000JPY
GoodwillCurrentQuarterInstant354000000JPY
Other iaPrior1YearInstant4863000000JPY
Other iaCurrentQuarterInstant5179000000JPY
Intangible assetsPrior1YearInstant5377000000JPY
Intangible assetsCurrentQuarterInstant5534000000JPY
Other ioaPrior1YearInstant88067000000JPY
Other ioaCurrentQuarterInstant84617000000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-1947000000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-1776000000JPY
Investments and other assetsPrior1YearInstant86120000000JPY
Investments and other assetsCurrentQuarterInstant82840000000JPY
Noncurrent assetsPrior1YearInstant181768000000JPY
Noncurrent assetsCurrentQuarterInstant176986000000JPY
AssetsPrior1YearInstant715288000000JPY
AssetsCurrentQuarterInstant804873000000JPY
Notes and accounts payable tradePrior1YearInstant385140000000JPY
Notes and accounts payable tradeCurrentQuarterInstant473899000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass